Literature DB >> 15033513

State-dependent inhibition of L-type calcium channels: cell-based assay in high-throughput format.

Menghang Xia1, John P Imredy, Ken S Koblan, Paul Bennett, Thomas M Connolly.   

Abstract

The current studies describe a new, robust cell-based functional assay useful to characterize L-type voltage-dependent calcium channels and their antagonists. The basis of this assay is measurement in plate format of Ca2+ influx through the L-type Ca2+ channel complex (alpha1C, alpha2delta, and beta2a subunits) in response to potassium-mediated depolarization; EC(50)=11 mM [K+](o). The Ca2+ influx was inhibited by the L-type Ca2+ channel antagonist, nimodipine; IC(50)=59 nM. These cells were also transfected with the Kir2.3 inward rectifier K(+) channel, which allows for changing the cell membrane potential by modulation of extracellular [K](o); -65 mV in physiological [K](o) and -28 mV in 30 mM [K](o) containing buffer. The conformational state of the voltage-sensitive Ca2+ channel is altered under these different conditions. Under the depolarized condition, nimodipine was a more potent antagonist, inhibiting Ca2+ influx with an IC(50) value of 3 nM. The results demonstrate that the interaction of nimodipine and other antagonists with the channel is modulated by changes in membrane potential and thus the state of the channel. Overall, this novel assay can be used to identify state-dependent calcium channel antagonists and should be useful for evaluating state-dependent inhibitory potency of a large number of samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033513     DOI: 10.1016/j.ab.2004.01.003

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.

Authors:  Menghang Xia; Sampada A Shahane; Ruili Huang; Steven A Titus; Enoch Shum; Yong Zhao; Noel Southall; Wei Zheng; Kristine L Witt; Raymond R Tice; Christopher P Austin
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-26       Impact factor: 4.219

2.  Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.

Authors:  Timothy A Vortherms; Andrew M Swensen; Wende Niforatos; James T Limberis; Torben R Neelands; Richard S Janis; Rama Thimmapaya; Diana L Donnelly-Roberts; Marian T Namovic; Di Zhang; C Brent Putman; Ruth L Martin; Carol S Surowy; Michael F Jarvis; Victoria E Scott
Journal:  Inflamm Res       Date:  2011-03-11       Impact factor: 4.575

3.  Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel Antagonists.

Authors:  James C Barrow; Kenneth E Rittle; Thomas S Reger; Zhi-Qiang Yang; Phung Bondiskey; Georgia B McGaughey; Mark G Bock; George D Hartman; Cuyue Tang; Jeanine Ballard; Yuhsin Kuo; Thomayant Prueksaritanont; Cindy E Nuss; Scott M Doran; Steven V Fox; Susan L Garson; Richard L Kraus; Yuxing Li; Michael J Marino; Valerie Kuzmick Graufelds; Victor N Uebele; John J Renger
Journal:  ACS Med Chem Lett       Date:  2010-02-01       Impact factor: 4.345

4.  Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.

Authors:  Zhi-Qiang Yang; Kelly-Ann S Schlegel; Youheng Shu; Thomas S Reger; Rowena Cube; Christa Mattern; Paul J Coleman; Jim Small; George D Hartman; Jeanine Ballard; Cuyue Tang; Yuhsin Kuo; Thomayant Prueksaritanont; Cindy E Nuss; Scott Doran; Steve V Fox; Susan L Garson; Yuxing Li; Richard L Kraus; Victor N Uebele; Adekemi B Taylor; Wei Zeng; Wei Fang; Cynthia Chavez-Eng; Matthew D Troyer; Julie Ann Luk; Tine Laethem; William O Cook; John J Renger; James C Barrow
Journal:  ACS Med Chem Lett       Date:  2010-08-24       Impact factor: 4.345

5.  Synthesis and Biological Evaluation of Pentacycloundecylamines and Triquinylamines as Voltage-Gated Calcium Channel Blockers.

Authors:  Lois-May Young; Werner J Geldenhuys; Olwen C Domingo; Sarel F Malan; Cornelis J Van der Schyf
Journal:  Arch Pharm (Weinheim)       Date:  2016-02-19       Impact factor: 3.751

6.  T-type calcium channels regulate cortical plasticity in-vivo. [corrected].

Authors:  Victor N Uebele; Cindy E Nuss; Vincent P Santarelli; Susan L Garson; Richard L Kraus; James C Barrow; Shaun R Stauffer; Kenneth S Koblan; John J Renger; Sara Aton; Julie Seibt; Michelle Dumoulin; Sushil K Jha; Tammi Coleman; Marcos G Frank
Journal:  Neuroreport       Date:  2009-02-18       Impact factor: 1.837

7.  Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles.

Authors:  Ruili Huang; Menghang Xia; Srilatha Sakamuru; Jinghua Zhao; Caitlin Lynch; Tongan Zhao; Hu Zhu; Christopher P Austin; Anton Simeonov
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

8.  Combining an in silico proarrhythmic risk assay with a tPKPD model to predict QTc interval prolongation in the anesthetized guinea pig assay.

Authors:  Pierre Morissette; Sebastian Polak; Anne Chain; Jin Zhai; John P Imredy; Mary Jo Wildey; Jeffrey Travis; Kevin Fitzgerald; Patrick Fanelli; Elisa Passini; Blanca Rodriguez; Frederick Sannajust; Christopher Regan
Journal:  Toxicol Appl Pharmacol       Date:  2020-01-23       Impact factor: 4.219

9.  Development of phenotypic assays for identifying novel blockers of L-type calcium channels in neurons.

Authors:  Rebecca Hagan; Elizabeth Rex; David Woody; Monika Milewski; Thomas Glaza; Michael P Maher; Yi Liu
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

10.  Ion channels as drug targets: the next GPCRs.

Authors:  Gregory J Kaczorowski; Owen B McManus; Birgit T Priest; Maria L Garcia
Journal:  J Gen Physiol       Date:  2008-04-14       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.